Brochure
More information from http://www.researchandmarkets.com/reports/3422625/
Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound,
Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs
Medical device Manufacturers), Product (Services, software), and Region
-Global Forecast to 2020
Description: Clinical imaging is the technique and process used to create images of the human body for clinical purposes to reveal, diagnose or examine diseases including study of normal anatomy and physiology. Clinical trials imaging use has rapidly increased in all phases of the clinical trial. This market report studies the potential of services, and software for diagnostic imaging and research and development.
The major drivers for the market include the growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs are driving the growth of the clinical trials imaging market. On the other hand high implementation cost of imaging systems are the major factors restraining the growth of this market.
This report segments the global market by product, modality, end-user, and geography. By product, the market includes services & software. The services segment is further divided into operational imaging services, systems & technology, reader services & design consulting. The modality segment includes CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The end-user segments included in this report are pharmaceutical companies, biotechnology companies, medical device companies/manufacturers, CROs & academic and government research institutes.
Geographic analysis reveals that North America accounted for the largest share of the global clinical trials imaging market in 2015. Growth in this market can be attributed to the increase in growth of pharmaceutical & biotechnology companies. The Asian regional segment, on the other hand, is expected to register a double -digit growth from 2015 to 2020, owing to the expansion of leading companies and increased R&D spending. R&D spending in Asia increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. The R&D spending in Asia accounted for 27.13% of global R&D expenditure in 2010.
The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), VirtualScopic, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).
Scope of the Report
This research report categorizes the global clinical trials imaging market into the following segments and subsegments:
Global Clinical Trials Imaging Market, by Product
- Services
- Operational Imaging Services - Reader Services
- System & Technology - Design Consulting - Software
Global Clinical Trials Imaging Market, by Modality
- CT - MRI - Ultrasound - PET - X-Rays - ECHO
- Other Modalities
Global Clinical Trials Imaging Market, by End-User
- Pharmaceutical Companies - Biotechnology Companies
- Medical Device Companies/Manufacturers - CROs
- Academic & Government Research Institutes - Other End-Users
Global Clinical Trials Imaging Market, by Geography
- North America - Europe - Asia
- Rest of the World
Contents: 1 Introduction
1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report 1.4 Currency
1.5 Limitation 1.6 Stakeholders
2 Research Methodology 2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation 2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources 2.3.2 Key Data From Primary Sources 2.3.3 Assumptions for the Study
3 Executive Summary
4 Premium Insights 4.1Market Overview
4.2 Life Cycle Analysis, By Region
5 Market Overview 5.1 Introduction 5.2 Market Segmentation 5.2.1 By Product 5.2.2 By Modality 5.2.3 By End User 5.3 Market Dynamics 5.3.1 Drivers
5.3.1.1 Increase in R&D Spending
5.3.1.2 Growth in the Pharmaceutical and Biotechnology Industries 5.3.1.3 Increasing Number of Cros
5.3.2 Restraints
5.3.2.1 High Implementation Cost of Imaging Systems 5.3.3 Opportunities
5.3.3.1 Emerging Economies
5.3.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, & Radiopharmaceuticals
5.3.4 Challenges
5.3.4.1 High Cost of Clinical Trials 5.3.4.2 High Cost of Pet
5.3.5 Trends
5.3.5.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials
6 Clinical Trials Imaging Market, By Product 6.1 Introduction
6.2 Services
6.2.1 Operational Imaging Services 6.2.2 Read Analysis Services
6.2.3 System and Technical Support Services 6.2.4 Trial Design Consulting Services 6.3 Software
7 Clinical Trials Imaging Market, By Modality 7.1 Introduction
7.2 Computed Tomography 7.3 Magnetic Resonance Imaging 7.4 Ultrasound
7.5 Positron Emission Tomography 7.6 X-Ray
7.7 Echocardiography 7.8 Other Modalities
8 Clinical Trials Imaging Market, By End User 8.1 Introduction
8.2 Pharmaceutical Companies 8.3 Biotechnology Companies 8.4 Medical Device Manufacturers 8.5 Contract Research Organizations
8.6 Academic and Government Research Institutes 8.7 Other End Users
9 Geographic Analysis 9.1 Introduction 9.2 North America 9.3 Europe 9.4 Asia
9.5 Rest of the World (RoW)
10 Competitive Landscape 10.1 Introduction 10.2 Strategic Overview
10.3 Leading Players in the Market 10.4 Competitive Situation and Trends
10.4.1 Agreements, Collaborations, and Partnerships 10.4.2 Acquisitions
10.4.3 New Product and Service Launches & Product Upgrades 10.4.4 Expansions 10.4.5 Other Developments 11 Company Profiles 11.1 Introduction 11.2 Bioclinica, Inc. 11.2.1 Business Overview 11.2.2 Services Offered 11.2.3 Recent Developments 11.2.4 MnM View
11.3 Parexel International Corporation 11.3.1 Business Overview 11.3.2 Services Offered 11.3.3 Recent Developments 11.3.4 MnM View 11.3.4.1 Financial Analysis 11.3.4.2 Strategic Analysis
11.4 Icon Public Limited Company 11.4.1 Business Overview 11.4.2 Services Offered 11.4.3 Recent Developments 11.4.4 MnM View 11.4.4.1 Financial Analysis 11.4.4.2 Strategic Analysis 11.5 Biomedical Systems Corporation 11.5.1 Business Overview 11.5.2 Services Offered 11.5.3 Recent Developments 11.5.4 MnM View 11.6 Virtualscopics, Inc. 11.6.1 Business Overview 11.6.2 Services Offered 11.6.3 Recent Development 11.6.4 MnM View 11.6.4.1 Financial Analysis 11.6.4.2 Strategic Analysis
11.7 Cardiovascular Imaging Technologies, LLC 11.7.1 Business Overview
11.7.2 Products & Services Offered 11.8 Intrinsic Imaging LLC 11.8.1 Business Overview 11.8.2 Services Offered 11.8.3 Recent Developments 11.9 Ixico PLC 11.9.1 Business Overview
11.9.2 Products & Services Offered 11.9.3 Recent Developments 11.10 Radiant Sage LLC
11.10.1 Business Overview
11.10.2 Products & Services Offered 11.10.3 Recent Developments 11.11 Worldcare Clinical, LLC 11.11.1 Business Overview 11.11.2 Services Offered 11.11.3 Recent Developments 12 Appendix
12.1 Insights of Industry Experts 12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing RT: Real-Time Market Intelligence 12.5 Available Customizations
12.6 Related Reports
List of Tables
Table 1 Market Summary
Table 2 Increase in R&D Spending is Propelling the Growth of the Market
Table 3 High Implementation Cost of Imaging Systems to Restrain Market Growth Table 4 Emerging Economies Offer Significant Growth Opportunities
Table 5 High Cost of Clinical Trials Pose A Challenge for the Market
Table 6 Rising Demand for Multimodality Imaging Technology in Clinical Trials is A Major Trend Observed in This Market
Table 7 Clinical Trials Imaging Market Size, By Product, 2013 - 2020 (USD Million) Table 8 Clinical Trials Imaging Services Market Size, By Type, 2013 - 2020 (USD Million) Table 9 Clinical Trials Imaging Services Market Size, By Region, 2013 - 2020 (USD Million)
Table 10 North America: Clinical Trials Imaging Services Market Size, By Country, 2013 - 2020 (USD Million) Table 11 Clinical Trials Imaging Market Size for Operational Imaging Services, By Region, 2013 - 2020 (USD Million)
Table 13 Clinical Trials Imaging Market Size for Read Analysis Services, By Region, 2013 - 2020 (USD Million) Table 14 North America: Market Size for Read Analysis Services, By Country, 2013 - 2020 (USD Million) Table 15 Market Size for System and Technical Support Services, By Region, 2013 - 2020 (USD Million) Table 16 North America: Market Size for System and Technical Support Services, By Country, 2013 - 2020 (USD Million)
Table 17 Market Size for Trial Design Consulting Services, By Region, 2013 - 2020 (USD Million)
Table 18 North America: Market Size for Trial Design Consulting Services, By Country, 2013 - 2020 (USD Million)
Table 19 Software Market Size, By Region, 2013 - 2020 (USD Million)
Table 20 North America: Software Market Size, By Country, 2013 - 2020 (USD Million) Table 21 Market Size, By Modality, 2013 - 2020 (USD Million)
Table 22 Market Size for CT, By Region, 2013 - 2020 (USD Million)
Table 23 North America: Market Size for CT, By Country, 2013 - 2020 (USD Million) Table 24 Market Size for Mri, By Region, 2013 - 2020 (USD Million)
Table 25 North America: Market Size for Mri, By Country, 2013 - 2020 (USD Million) Table 26 Market Size for Ultrasound, By Region, 2013 - 2020 (USD Million)
Table 27 North America: Market Size for Ultrasound, By Country, 2013 - 2020 (USD Million) Table 28 Market Size for Pet, By Region, 2013 - 2020 (USD Million)
Table 29 North America: Market Size for Pet, By Country, 2013 - 2020 (USD Million) Table 30 Market Size for X-Ray, By Region, 2013 - 2020 (USD Million)
Table 31 North America: Market Size for X-Ray, By Country, 2013 - 2020 (USD Million) Table 32 Market Size for Echocardiography, By Region, 2013 - 2020 (USD Million)
Table 33 North America: Market Size for Echocardiography, By Country, 2013 - 2020 (USD Million) Table 34 Clinical Trials Imaging Market Size for Other Modalities, By Region, 2013 - 2020 (USD Million) Table 35 North America: Market Size for Other Modalities, By Country, 2013 - 2020 (USD Million) Table 36 Market Size, By End User, 2013 - 2020 (USD Million)
Table 37 Market Size for Pharmaceutical Companies, By Region, 2013 - 2020 (USD Million)
Table 38 North America: Market Size for Pharmaceutical Companies, By Country, 2013 - 2020 (USD Million) Table 39 Market Size for Biotechnology Companies, By Region, 2013 - 2020 (USD Million)
Table 40 North America: Market Size for Biotechnology Companies, By Country, 2013 - 2020 (USD Million) Table 41 Market Size for Medical Device Manufacturers, By Region, 2013 - 2020 (USD Million)
Table 42 North America: Market Size for Medical Device Manufacturers, By Country, 2013 - 2020 (USD Million)
Table 43 Market Size for Cros, By Region, 2013 - 2020 (USD Million)
Table 44 North America: Market Size for Cros, By Country, 2013 - 2020 (USD Million)
Table 45 Clinical Trials Imaging Market Size for Academic and Government Research Institutes, By Region, 2013 - 2020 (USD Million)
Table 46 North America: Market Size for Academic and Government Research Institutes, By Country, 2013 -2020 (USD Million)
Table 47 Market Size for Other End Users, By Region, 2013 - 2020 (USD Million)
Table 48 North America: Market Size for Other End Users, By Country, 2013 - 2020 (USD Million) Table 49 Market Size, By Region, 2013 - 2020 (USD Million)
Table 50 North America: Market Size, By Country, 2013 - 2020 (USD Million) Table 51 North America: Market Size, By Product, 2013 - 2020 (USD Million)
Table 52 North America: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million) Table 53 North America: Market Size, By Modality, 2013 - 2020 (USD Million)
Table 54 North America: Market Size, By End User, 2013 - 2020 (USD Million) Table 55 Europe: Market Size, By Product, 2013 - 2020 (USD Million)
Table 56 Europe: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million) Table 57 Europe: Market Size, By Modality, 2013 - 2020 (USD Million)
Table 58 Europe: Market Size, By End User, 2013 - 2020 (USD Million) Table 59 Asia: Market Size, By Product, 2013 - 2020 (USD Million)
Table 60 Asia: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million) Table 61 Asia: Market Size, By Modality, 2013 - 2020 (USD Million)
Table 62 Asia: Market Size, By End User, 2013 - 2020 (USD Million) Table 63 RoW: Market Size, By Product, 2013 - 2020 (USD Million)
Table 64 RoW: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million) Table 65 RoW: Market Size, By Modality, 2013 - 2020 (USD Million)
Table 66 RoW: Market Size, By End User, 2013 - 2020 (USD Million)
Table 67 Rank of Companies in the Global Clinical Trials Imaging Market, 2015
Table 68 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Players Between January 2013 and August 2015
Table 70 Acquisitions, 2013 - 2015
Table 71 New Product and Service Launches & Product Upgrades, 2013 - 2015 Table 72 Expansions, 2013 - 2015
Table 73 Other Developments, 2013 - 2015
List of Figures
Figure 1 Clinical Trials Imaging Market Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region Figure 6 Data Triangulation Methodology
Figure 7 Clinical Trials Imaging Market Size, By Product, 2015 vs 2020 (USD Million) Figure 8 Market Size, By Modality, 2015 vs 2020 (USD Million)
Figure 9 Market Size, By End User, 2015 vs 2020 (USD Million) Figure 10 Clinical Trials Imaging Market: Geographic Snapshot (2015) Figure 11 Market Size, By Region, 2015 vs 2020 (USD Million)
Figure 12 Emerging Economies Offer Significant Growth Opportunities for Market Growth Figure 13 Services Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period Figure 15 North America Market Segment Headed Toward Maturity Figure 16 Clinical Trials Imaging Market: By Product
Figure 17 Clinical Trials Imaging Market: By Modality Figure 18 Clinical Trials Imaging Market: By End User Figure 19 Increase in R&D Spending Will Drive the Market Figure 20 Increasing R&D Funding Boosting Growth in the Market Figure 21 Number of Biotechnology Patents, By Country, 2012 Figure 22 Market Segmentation, By Product
Figure 23 Clinical Trials Imaging Services to Form the Largest Segment in 2015
Figure 24 Operational Imaging Services to Form the Largest and Fastest-Growing Segment in the Forecast Period
Figure 25 North America to Command Largest Share of the Clinical Trials Imaging Services Market in 2015 Figure 26 Asia to Be the Fastest-Growing Segment of the Operational Imaging Services Market in the Forecast Period
Figure 27 North America to Form the Largest Segment of the Read Analysis Services Market in 2015
Figure 28 Asia to Form the Fastest-Growing Segment of the System and Technical Support Services Market in the Forecast Period
Figure 29 North America to Command Largest Share of the Trial Design Consulting Services Market in the Forecast Period
Figure 30 Asia to Be the Fastest-Growing Segment of the Clinical Trials Imaging Software Market in the Forecast Period
Figure 31 Market Segmentation, By Modality
Figure 32 CT Segment to Command the Largest Share of the Market in 2015
Figure 33 North America Expected to Dominate the Clinical Trials Imaging Market for CT Figure 34 Asia to Witness Highest Growth in the Market for Mri in the Forecast Period Figure 35 North America Expected to Form the Largest Regional Segment for Ultrasound
Figure 36 Asia Expected to Be the Fastest-Growing Regional Segment for Pet Market Between 2015 and 2020 Figure 37 X-Ray Market in Asia to Witness Highest Growth in the Forecast Period
Figure 38 Echocardiography Segment to Witness Highest Growth in Asia Figure 39 North America Dominates the Market for Other Modalities Figure 40 Clinical Trials Imaging Market, By End User
Figure 41 Clinical Trials Imaging Market Size, By End User, 2015 (USD Million)
Figure 42 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region Figure 43 Pharmaceutical Companies Segment to Witness Highest Growth in Asia
Figure 44 North America to Command the Largest Share of the Biotechnology Companies Segment in 2020 Figure 45 North America to Dominate the Market for Medical Device Manufacturers in 2020
Figure 46 North America Expected to Dominate the Market for Cros
Figure 47 Public-Sector Research Funding is Driving the Growth of the Academic & Government Research Institutes End-User Segment
Figure 48 North America Dominates the Market for Academic and Government Research Institutes
Figure 49 Asia to Witness the Highest Growth in the Clinical Trials Imaging Market for Other End Users in the Forecast Period
Figure 50 Clinical Trials Imaging Market, By Region (Market Size and Growth Rate), 2015-2020
Figure 51 Clinical Trials Imaging Market in Asia Expected to Grow at the Highest Rate From 2015 to 2020 Figure 52 North America: Market Snapshot
Figure 53 U.S. Forms the Fastest-Growing Market in North America in 2015
Figure 54 Services are Estimated to Be the Largest Product Segment in North America (2015) Figure 55 Operational Imaging Largest Services Segment in North America (2015)
Figure 56 CT Expected to Form for the Largest Modality Segment in North America in 2015
Figure 57 Pharmaceutical Companies to Form the Largest End-User Segment in North America in 2015 Figure 58 Services to Form the Largest Product Segment in Europe 2015
Figure 59 Operational Imaging Accounted for the Largest Share in the European Clinical Trials Imaging Market in 2015
Figure 60 CT Segment to Command the Largest Share of the European Clinical Trials Imaging Market in 2015 Figure 61 Pharmaceutical Companies to Form the Largest End-User Segment in Europe in 2015
Figure 62 Asia: Market Snapshot
Figure 63 Services to Form the Largest Product Segment in Asia (2015)
Figure 64 Operational Imaging to Form the Largest Services Segment in Asia in 2015 Figure 65 CT Segment to Account for the Largest Share of the Market in Asia
Figure 66 Pharmaceutical Companies to Form the Largest End-User Segment in Asia in 2015 Figure 67 Services to Form the Largest Product Segment in the RoW in 2015
Figure 68 Operational Imaging to Command the Largest Share in the RoW Clinical Trials Imaging Market (2015)
Figure 69 CT to Form the Largest Modality Segment in RoW in 2015
Figure 70 Pharmaceutical Companies to Form the Largest End-User Segment in RoW in 2015
Figure 71 Agreements, Partnerships, and Collaborations is the Key Growth Strategy Adopted By Players in the Market
Figure 72 Market Developments Between January 2013 and August 2015 Figure 73 Company Snapshot: Parexel International Corporation
Figure 74 Company Snapshot: Icon Public Limited Company Figure 75 Company Snapshot: Virtualscopics, Inc.
Figure 76 Company Snapshot: Ixico PLC
Ordering: Order Online - http://www.researchandmarkets.com/reports/3422625/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Formats
Please select the product formats and quantity you require:
Contact Information
Please enter all the information below in BLOCK CAPITALS
Product Name: Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound,
Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020
Web Address: http://www.researchandmarkets.com/reports/3422625/
Office Code: SC
Quantity
Electronic (PDF)
-Single User: USD 4650 Electronic (PDF)
-1 - 5 Users: USD 5650 Electronic (PDF)
-Site License: USD 7150 Electronic (PDF)
-Enterprisewide: USD 9000
Title: Mr Mrs Dr Miss Ms Prof
First Name: Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World
Pay by credit card: You will receive an email with a link to a secure webpage to enter yourcredit card details.
Pay by check: Please post the check, accompanied by this form, to: Research and Markets,
Guinness Center, Taylors Lane, Dublin 8, Ireland.
Pay by wire transfer: Please transfer funds to:
Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D
IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank,
27-35 Main Street, Blackrock, Co. Dublin, Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
